Jennifer Panganiban, MD
Assistant Professor of Clinical Pediatrics (Gastroenterology, Hepatology and Nutrition)
Medical Director, Non Alcoholic Fatty Liver Disease Program, Children's Hospital of Philadelphia
Medical Director, Nutrition Support Service, Children's Hospital of Philadelphia
Co-Director, Nutrition Fellowship, Children's Hospital of Philadelphia
Department: Pediatrics
Contact information
Children's Hospital of Philadelphia
Division of GI, Hepatology and Nutrition
34th and Civic Center Boulevard
Philadelphia, PA 19104
Division of GI, Hepatology and Nutrition
34th and Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-590-3630
Fax: 215-590-3606
Fax: 215-590-3606
Email:
panganibaj@chop.edu
panganibaj@chop.edu
Education:
BS (Biology)
University of Santo Tomas, Manila, Philippines, 2001.
MD
University of Santo Tomas, Manila, Philippines, 2005.
Permanent linkBS (Biology)
University of Santo Tomas, Manila, Philippines, 2001.
MD
University of Santo Tomas, Manila, Philippines, 2005.
Description of Clinical Expertise
https://www.chop.edu/centers-programs/non-alcoholic-fatty-liver-disease-clinichttps://www.chop.edu/conditions-diseases/non-alcoholic-fatty-liver-disease-nafld
https://www.chop.edu/news/childrens-hospital-philadelphia-celebrates-nashday
Description of Research Expertise
Introduction to Pediatric NAFLD Series - Panganiban - 2021 - Clinical Liver Disease - Wiley Online Library https://doi.org/10.1002/cld.1036Selected Publications
Kelsey Olinik CRNP, Alanna Strong MD, Jennifer Panganiban MD: LIVER DISEASE IN OFD-1 CILIOPATHY. accepted for the NASPGHAN annual meeting 2023 2023.Sindu Vellanki, Jennifer Panganiban and Maria Mascarenhas: Pediatric Inflammatory Bowel Disease 4th Edition Chapter on Complementary and Alternative Therapies for IBD. Springer. Petar Mamula, Judith Kelsen, (eds.). Springer, 4, 2023.
Andrea Tou MD and Jennifer Panganiban MD: GLP-1 RECEPTOR AGONISTS AS A TREATMENT FOR PEDIATRIC NON-ALCOHOLIC FATTY LIVER DISEASE. accepted for NASPGHAN annual meeting, 2023 2023.
Kohut, Taisa MD1; Shah, Amit MD2; Russo, Pierre MD3; Panganiban, Jennifer MD2: Autoimmune Antibodies in Children and Adolescents with Nonalcoholic Fatty Liver Disease. Journal of Pediatric Gastroenterology and Nutrition 10(1): 1097, June 2022.
Rothman, J, Dowshen, N and Panganiban J.: E-cigarette, or vaping, product use associated lung injury (EVALI) presenting with profoundly elevated liver enzymes: Two case reports. Poster, North American Society For Pediatric Gastroenterology, Hepatology & Nutrition National Conference, Virtual December 2021.
Yu, E, Panganiban J, Schwimmer, F: Exercise practices, preferences and barriers in pediatric patients with nonalcoholic fatty liver disease. Poster, North American Society For Pediatric Gastroenterology, Hepatology & Nutrition National Conference, Virtual December 2021.
Kohut, T and Panganiban J. : Transient Autoantibody Seropositivity in Children with NAFLD. Poster, North American Society For Pediatric Gastroenterology, Hepatology & Nutrition National Conference, Virtual December 2021.
Kohut, T and Panganiban J: Liraglutide with Lifestyle Intervention in Adolescents with Overweight/Obesity, Nonalcoholic Fatty Liver Disease, and Type II Diabetes Mellitus" JPGN Reports 2(14): e141, November 2021.
Kohut, T, Seraj S and Panganiban J: Utilization of Topiramate as an Adjunct to Lifestyle Intervention for Weight Loss in Pediatric Nonalcoholic Fatty Liver Disease (NAFLD). JPGN Reports 2(12): e126, November 2021.
Mitrani R, Kohut T, Panganiban J and Carr R: Transition of Care Model for Pediatric Patients with NAFLD. Clinical Liver Disease 12(11): 617-28, August 2021.